Market Cap 895.97M
Revenue (ttm) 74.21M
Net Income (ttm) -521.96M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -703.36%
Debt to Equity Ratio 0.00
Volume 1,892,300
Avg Vol 1,475,252
Day's Range N/A - N/A
Shares Out 139.13M
Stochastic %K 83%
Beta 1.27
Analysts Strong Sell
Price Target $17.22

Company Profile

Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally. Its clinical development pipeline consists of product investigational therapies targeting hepatitis delta virus (HDV) and other solid tumors.The company's preclinical candidates include those targeting influenza A and B, coronavirus disease 2019, respiratory syncytial virus (RSV) and human metap...

Industry: Biotechnology
Sector: Healthcare
Phone: 415 906 4324
Website: www.vir.bio
Address:
1800 Owens Street, Suite 900, San Francisco, United States
Dunnieboy1
Dunnieboy1 Nov. 27 at 9:44 AM
$VIR markets are closed today and finish early tomorrow for thanksgiving.
0 · Reply
TDMF123
TDMF123 Nov. 27 at 3:17 AM
$VIR To be clear, after SoftBank approved the planned sale in September, they began selling in October and would go a few days on then pull back then commenced again etc. Was just curious if anyone had any more detail on how they typically may go about it and if we should expect a Form 4 on a regular 1-2 day drop
1 · Reply
TDMF123
TDMF123 Nov. 26 at 11:24 PM
$VIR anyone have an idea of these soft bank sales these last few days? It’s definitely suppressing price action. Hoping it’s not going to be an everyday occurrence going forward but rather sporadic etc
0 · Reply
sittingonagoldmine
sittingonagoldmine Nov. 26 at 9:48 PM
$VIR I am still here & convinced! Did anyone realize the communication change of Marianne during her last call presentation @ Jeffries? She mentioned, by executing on their strategic priorities, they believe that „they can CREATE SIGNIFICANT VALUE FOR SHAREHOLDERS while transforming patient´s lives.“ (last 2 minutes of call) Historically (last 2 years), there was a lack of mentioning of shareholders and their interests at the calls, in my view. For the next few months, Marianne´s experience as a „deal maker“ will help to find the right partners ex US for HDV. Also, the lower toxicity of VIR s cancer treatments gives us a competitive advantage, although we are in early stages (Phase I) in oncology. I am seeing VIR as a long-term play. They will make money on a monthly basis (continuous dosing of best-in-class chronic HDV treatment, once approved), then use the proceeds to get their oncology platform to FDA approvals, making a lot more money in the future. Good luck to all VIR bulls!
1 · Reply
SannieVerraderlijk
SannieVerraderlijk Nov. 26 at 1:06 PM
$VIR 800M cash, starter before JANX
0 · Reply
Iightning
Iightning Nov. 26 at 4:20 AM
1ightning® Options Trade Alert (Actionable) | Buy $VIR Dec 19 $7 Call | Enter: $0.20 Exit: $0.35 | Profit: 73.90% ROI | https://1ightning.com
0 · Reply
ignoreo
ignoreo Nov. 26 at 1:28 AM
$VIR risk-free 10x in 1 year btw
0 · Reply
justiceforb_85
justiceforb_85 Nov. 26 at 12:35 AM
$VIR how much is the company worth for the HDV program?
0 · Reply
metalcook
metalcook Nov. 25 at 4:59 PM
$VIR is basically a cheap call option if JANX manages to impress with data next week.
2 · Reply
Iightning
Iightning Nov. 25 at 2:27 PM
1ightning® Options Trade Alert (Actionable) | Buy $VIR Dec 19 $7 Call | Enter: $0.20 Exit: $0.35 | Profit: 73.90% ROI | https://1ightning.com
0 · Reply
Latest News on VIR
Vir (VIR) Q2 Revenue Drops 61%

Aug 7, 2025, 12:32 AM EDT - 4 months ago

Vir (VIR) Q2 Revenue Drops 61%


Vir Biotechnology, Inc. (VIR) Q2 2025 Earnings Call Transcript

Aug 6, 2025, 11:01 PM EDT - 4 months ago

Vir Biotechnology, Inc. (VIR) Q2 2025 Earnings Call Transcript


Vir Biotechnology: Hep B And Cancer Projects March On

Jul 23, 2025, 12:10 PM EDT - 4 months ago

Vir Biotechnology: Hep B And Cancer Projects March On


Vir Biotechnology, Inc. (VIR) Q1 2025 Earnings Call Transcript

May 7, 2025, 11:21 PM EDT - 7 months ago

Vir Biotechnology, Inc. (VIR) Q1 2025 Earnings Call Transcript


Vir Biotechnology, Inc. (VIR) Q4 2024 Earnings Call Transcript

Feb 26, 2025, 11:22 PM EST - 9 months ago

Vir Biotechnology, Inc. (VIR) Q4 2024 Earnings Call Transcript


Vir Biotechnology: A Rocket Off Phase 1 Data

Jan 9, 2025, 9:00 AM EST - 11 months ago

Vir Biotechnology: A Rocket Off Phase 1 Data


Vir Biotechnology, Inc. (VIR) Q3 2024 Earnings Call Transcript

Oct 31, 2024, 11:12 PM EDT - 1 year ago

Vir Biotechnology, Inc. (VIR) Q3 2024 Earnings Call Transcript


Dunnieboy1
Dunnieboy1 Nov. 27 at 9:44 AM
$VIR markets are closed today and finish early tomorrow for thanksgiving.
0 · Reply
TDMF123
TDMF123 Nov. 27 at 3:17 AM
$VIR To be clear, after SoftBank approved the planned sale in September, they began selling in October and would go a few days on then pull back then commenced again etc. Was just curious if anyone had any more detail on how they typically may go about it and if we should expect a Form 4 on a regular 1-2 day drop
1 · Reply
TDMF123
TDMF123 Nov. 26 at 11:24 PM
$VIR anyone have an idea of these soft bank sales these last few days? It’s definitely suppressing price action. Hoping it’s not going to be an everyday occurrence going forward but rather sporadic etc
0 · Reply
sittingonagoldmine
sittingonagoldmine Nov. 26 at 9:48 PM
$VIR I am still here & convinced! Did anyone realize the communication change of Marianne during her last call presentation @ Jeffries? She mentioned, by executing on their strategic priorities, they believe that „they can CREATE SIGNIFICANT VALUE FOR SHAREHOLDERS while transforming patient´s lives.“ (last 2 minutes of call) Historically (last 2 years), there was a lack of mentioning of shareholders and their interests at the calls, in my view. For the next few months, Marianne´s experience as a „deal maker“ will help to find the right partners ex US for HDV. Also, the lower toxicity of VIR s cancer treatments gives us a competitive advantage, although we are in early stages (Phase I) in oncology. I am seeing VIR as a long-term play. They will make money on a monthly basis (continuous dosing of best-in-class chronic HDV treatment, once approved), then use the proceeds to get their oncology platform to FDA approvals, making a lot more money in the future. Good luck to all VIR bulls!
1 · Reply
SannieVerraderlijk
SannieVerraderlijk Nov. 26 at 1:06 PM
$VIR 800M cash, starter before JANX
0 · Reply
Iightning
Iightning Nov. 26 at 4:20 AM
1ightning® Options Trade Alert (Actionable) | Buy $VIR Dec 19 $7 Call | Enter: $0.20 Exit: $0.35 | Profit: 73.90% ROI | https://1ightning.com
0 · Reply
ignoreo
ignoreo Nov. 26 at 1:28 AM
$VIR risk-free 10x in 1 year btw
0 · Reply
justiceforb_85
justiceforb_85 Nov. 26 at 12:35 AM
$VIR how much is the company worth for the HDV program?
0 · Reply
metalcook
metalcook Nov. 25 at 4:59 PM
$VIR is basically a cheap call option if JANX manages to impress with data next week.
2 · Reply
Iightning
Iightning Nov. 25 at 2:27 PM
1ightning® Options Trade Alert (Actionable) | Buy $VIR Dec 19 $7 Call | Enter: $0.20 Exit: $0.35 | Profit: 73.90% ROI | https://1ightning.com
0 · Reply
Dunnieboy1
Dunnieboy1 Nov. 25 at 8:01 AM
$VIR Vir pre-market is showing us currently up 18% earlier we were up over 24% at $7.24, although hugely unreliable it will certainly have anyone who is short in a sweat. The old timers here will remember when the Reddit & Robin Hood recommended their followers to start buying Vir as it was ’heavily shorted’, this created panic as the shorters scrambled to close their position and the price shot up to $141 in minutes, trading was halted as there was little stock available. When trading began again the price drifted back to i think 60/70 dollars for a few weeks, i’m not saying it will happen again, but it could, i believe there is not a lot of stock available in the open market which would cause panic if the news or the rumour was strong enough. I can smell the fear in the shorters from here🔥
2 · Reply
Iightning
Iightning Nov. 25 at 3:20 AM
1ightning® Options Trade Alert (Actionable) | Buy $VIR Dec 19 $7 Call | Enter: $0.20 Exit: $0.35 | Profit: 73.90% ROI | https://1ightning.com
0 · Reply
TDMF123
TDMF123 Nov. 24 at 5:34 PM
$VIR volume is much higher than normal this time of day by far. My guess is either the Re-Rate is making its way round Wall Street before it hits the normal channels or positions are being taken prior to Evecore next week. Something is brewing Any input is appreciated
1 · Reply
TDMF123
TDMF123 Nov. 24 at 1:46 AM
$VIR all in all it may be just a fluke but it’s definitely nice to see. Especially if it’s leading somewhere tomorrow etc
1 · Reply
TDMF123
TDMF123 Nov. 24 at 1:30 AM
$VIR I have been following it for months. It has NEVER traded overnight or least it hasn’t in the last 2-3 weeks. Tonight it’s sitting at $6.41 as of 8:28 PM EST Now I know overnight doesn’t matter, but the fact that it’s actually trading overnight is very interesting . Just thought I would share.
0 · Reply
mohdelo13
mohdelo13 Nov. 22 at 7:53 AM
$VIR alright I finally nibbled in for starter, 2500 shares and will start to slowly build. Read enough to see atleast leak at this biotech as a better gamble than most. Very high potential vs risk at these current prices imo. Do your own DD.
0 · Reply
merlin8121
merlin8121 Nov. 22 at 6:41 AM
$VIR https://www.youtube.com/shorts/_DSnrdOwvBg
0 · Reply
Iightning
Iightning Nov. 22 at 12:34 AM
1ightning® Options Trade Alert (Actionable) | Buy $VIR Dec 19 $6 Call | Enter: $0.17 Exit: $0.27 | Profit: 56.11% ROI | https://1ightning.com
0 · Reply
Dunnieboy1
Dunnieboy1 Nov. 21 at 7:41 AM
$VIR wrong date, i posted the Scrip Awards final was last night,in fact the final is being held on thursday 11 December in London.
0 · Reply
Iightning
Iightning Nov. 21 at 3:55 AM
1ightning® Options Trade Alert (Actionable) | Buy $VIR Dec 19 $6 Call | Enter: $0.17 Exit: $0.27 | Profit: 56.11% ROI | https://1ightning.com
0 · Reply
Iightning
Iightning Nov. 20 at 1:22 AM
1ightning® Options Trade Alert (Actionable) | Buy $VIR Dec 19 $6 Call | Enter: $0.17 Exit: $0.27 | Profit: 56.11% ROI | https://1ightning.com
0 · Reply
TDMF123
TDMF123 Nov. 20 at 1:04 AM
$VIR We just got a re rating from one of the institutions. Should be public in the AM
1 · Reply